Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 625 M644 M637 M689 M723 M723 M 2.77 B Research & development —————— — Operating income 1.27 B1.3 B1.33 B1.45 B1.42 B1.46 B 5.66 B Non-Operating Income, Total 21 M15 M15 M10 M18 M4 M 47 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 000000 0 Unusual income/expense 21 M15 M15 M10 M18 M4 M 47 M Pretax income 1.2 B1.23 B1.27 B1.4 B1.37 B1.41 B 5.45 B Equity in earnings —————— — Taxes 206 M218 M213 M256 M244 M247 M 960 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 994 M1.01 B1.06 B1.14 B1.13 B1.16 B 4.49 B Discontinued operations —————— — Net income 994 M1.01 B1.06 B1.14 B1.13 B1.16 B 4.49 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 994 M1.01 B1.06 B1.14 B1.13 B1.16 B 4.49 B Basic earnings per share (Basic EPS) 3.693.783.93—4.164.29 — Diluted earnings per share (Diluted EPS) 3.663.743.884.24.14.24 16.42 Average basic shares outstanding 269.04 M268.14 M269.23 M269.08 M270.17 M270.17 M — Diluted shares outstanding 271.75 M270.94 M272.64 M272.43 M274.13 M273.81 M — EBITDA 1.56 B1.42 B1.47 B1.75 B1.57 B1.6 B 6.38 B EBIT 1.18 B1.22 B1.26 B1.39 B1.35 B1.51 B 5.51 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 206 M206 M209 M364 M217 M87 M 877 M